Testing effectiveness (Phase 2)UnknownNCT04517526
What this trial is testing
Efficacy and Safety of Platinum-based Chemotherapy + Bevacizumab + Durvalumab, and Salvage SBRT for IV Non-Small Cell Lung Cancer Patients With EGFR Mutations After Failure of First Line Osimertinib: A Multicenter, Prospective, Phase II Clinical Study
Who this might be right for
Lung Cancer Stage IV，EGFR-mutant，TKI，PD-L1，SBRT
Shanghai Cancer Hospital, China 60